Adhera Therapeutics Inc (ATRX) Stock Price, Quote, News & History

ATRXOTCEM
$0.00010
At close: May 8, 5:00 PM EST
OverviewNews
Loading...

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 7.59K
Day Range
- - -
52 Wk Range
0.00 - 0.01
Market Cap
$722.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
-

Recent Adhera Therapeutics Inc News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-714.19K
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
613.54K
Free Cash Flow (TTM)
-714.19K
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-100.66K

Valuation Metrics

Enterprise Value
$722.00
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-

Company Debt

Total Debt
$10.83M
LT Debt
-
LT Debt Issuance (TTM)
$1.09M
LT Debt Repayment (TTM)
-
Total Cash
$32.39K
Debt to Equity
-
Issuance of Debt (TTM)
$1.09M
Repayment of Debt (TTM)
-$214.86K

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 7.59K
Day Range
- - -
52 Wk Range
0.00 - 0.01
Market Cap
$722.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
-

About

Sector
Health Care
Industry
Biotechnology
Adhera Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing advanced drug candidates through accelerated pathways. The company's pipeline includes MLR-1019 for Parkinson's disease and MLR-1023 for diabetes, both licens...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Adhera Therapeutics (ATRX) stock?

A

You can purchase shares of Adhera Therapeutics (OTCEM:ATRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Adhera Therapeutics (ATRX) competitors?

A

There are no as such competitors for Adhera Therapeutics.

Q

What is the forecast, or price target, for Adhera Therapeutics (ATRX) stock?

A

There is no analysis for Adhera Therapeutics to provide a consensus price target.

Q

What is the current price for Adhera Therapeutics (ATRX)?

A

The stock price for Adhera Therapeutics (OTCEM: ATRX) is $0.0001 last updated March 30, 2026 at 9:34 AM EDT.

Q

Does Adhera Therapeutics (ATRX) pay a dividend?

A

There are no upcoming dividends for Adhera Therapeutics.

Q

When is Adhera Therapeutics (OTCEM:ATRX) reporting earnings?

A

Adhera Therapeutics does not have any upcoming earnings scheduled.

Q

Is Adhera Therapeutics (ATRX) going to split?

A

There is no upcoming split for Adhera Therapeutics.

Q

What sector and industry does Adhera Therapeutics (ATRX) operate in?

A

Adhera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.